TY - JOUR
T1 - A Thermoresponsive injectable drug delivery system of chitosan/β-glycerophosphate with gellan gum/alginate microparticles
AU - Carrêlo, H.
AU - Jiménez-Rosado , M.
AU - Vieira, Tânia
AU - Da Rosa, Rafaela R.
AU - Perez-Puyana, Victor M.
AU - Silva, Jorge Carvalho
AU - Romero, A.
AU - Borges, J. P.
AU - Soares, Paula I. P.
N1 - Funding Information:
info:eu-repo/grantAgreement/FCT//SFRH%2FBD%2F144986%2F2019/PT#
This work is co-financed by FEDER, European funds, through the COMPETE 2020 POCI and PORL, National Funds through FCT – Portuguese Foundation for Science and Technology and POR Lisboa2020, under the project PIDDAC (POCI-01-0145-FEDER-007688, Reference UIDB/50025/2020-2023).
Authors want to acknowledge El Centro de Investigación, Tecnología e Innovación de la Universidad de Sevilla (CITIUS) for granting access to and their assistance with the Microanalysis and Microscopy service.
This work is a part of an I+D+i PID2021-124294OB-C21 project which is sponsored by MCIN/AEI/10.13039/501100011033
/ and “ERDF A way of making Europe”. The authors thank their financial support. In addition, the authors would also acknowledge the postdoctoral contract of Víctor M. Pérez Puyana from the “Contratación de Personal Investigador Doctor” supported by the European Social Fund and Junta de Andalucía (PAIDI DOCTOR – Convocatoria 2019-2020).
Funding Information:
This work is co-financed by FEDER , European funds, through the COMPETE 2020 POCI and PORL , National Funds through FCT \u2013 Portuguese Foundation for Science and Technology and POR Lisboa2020 , under the project PIDDAC ( POCI-01-0145-FEDER-007688 , Reference UIDB/50025/2020-2023 ). H.C. acknowledges FCT for the PhD grant with reference SFRH/BD/144986/2019 . Authors want to acknowledge El Centro de Investigaci\u00F3n, Tecnolog\u00EDa e Innovaci\u00F3n de la Universidad de Sevilla (CITIUS) for granting access to and their assistance with the Microanalysis and Microscopy service.
Publisher Copyright:
© 2024
PY - 2024/6
Y1 - 2024/6
N2 - The development of new Drug Delivery Systems (DDS) by incorporating microparticles within hydrogels can prolong the release rate of drugs and/or other bioactive agents. In this study, we combined gellan gum/alginate microparticles within a thermoresponsive chitosan (Ch) hydrogel with β-Glycerophosphate (β-GP), designing the system to be in the sol state at 21 °C and in the gel state at 37 °C to enable the injectability of the system. The system was in the sol state between 10 °C and 21 °C. Higher concentrations of β-GP (0, 2, 3, 4, 5 w/v%) and microparticles (0, 2 and 5 w/v%) allowed a faster sol-gel transition with higher mechanical strength at 37 °C. However, the sol-gel transition was not instantaneous. The release profile of methylene blue (MB) from the microparticles was significantly affected by their incorporation in Ch/β-GP hydrogels, only allowing the release of 60–70 % of MB for 6 days, while the microparticles alone released all the MB in 48 h. The proposed system did not present cytotoxicity to VERO cell lines as a preliminary assay, with the Ch/β-GP/GG:Alg having >90 % of cellular viability. The proposed Ch/β-GP system proved to have a delaying effect on drug release and biocompatible properties, being a promising future DDS.
AB - The development of new Drug Delivery Systems (DDS) by incorporating microparticles within hydrogels can prolong the release rate of drugs and/or other bioactive agents. In this study, we combined gellan gum/alginate microparticles within a thermoresponsive chitosan (Ch) hydrogel with β-Glycerophosphate (β-GP), designing the system to be in the sol state at 21 °C and in the gel state at 37 °C to enable the injectability of the system. The system was in the sol state between 10 °C and 21 °C. Higher concentrations of β-GP (0, 2, 3, 4, 5 w/v%) and microparticles (0, 2 and 5 w/v%) allowed a faster sol-gel transition with higher mechanical strength at 37 °C. However, the sol-gel transition was not instantaneous. The release profile of methylene blue (MB) from the microparticles was significantly affected by their incorporation in Ch/β-GP hydrogels, only allowing the release of 60–70 % of MB for 6 days, while the microparticles alone released all the MB in 48 h. The proposed system did not present cytotoxicity to VERO cell lines as a preliminary assay, with the Ch/β-GP/GG:Alg having >90 % of cellular viability. The proposed Ch/β-GP system proved to have a delaying effect on drug release and biocompatible properties, being a promising future DDS.
KW - Chitosan
KW - Hydrogels
KW - Microparticles
UR - http://www.scopus.com/inward/record.url?scp=85195371108&partnerID=8YFLogxK
U2 - 10.1016/j.ijbiomac.2024.131981
DO - 10.1016/j.ijbiomac.2024.131981
M3 - Article
C2 - 38811317
AN - SCOPUS:85195371108
SN - 0141-8130
VL - 271
JO - International Journal of Biological Macromolecules
JF - International Journal of Biological Macromolecules
M1 - 131981
ER -